publication . Preprint . 2011

Potential Effects of a Ban on Direct-to-Consumer Advertising of New Prescription Drugs

Congressional Budget Office;
Open Access
  • Published: 26 May 2011
Concerns about direct-to-consumer advertising of prescription drugs have spurred recent proposals for a moratorium on advertising brand-name prescription drugs to consumers during the first two years following a drug's approval by the Food and Drug Administration. This Congressional Budget Office brief examines some of the effects of such a moratorium, drawing on data documenting direct-to-consumer advertising and other promotional activities used by pharmaceutical producers as well as academic analyses of how advertising has affected the market for drugs.
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue